For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
2
views
0
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      812
      similar
       All similar
      • Record: found
      • Abstract: not found
      • Article: not found

      ORAL TREATMENT WITH RD2 REDUCES Aβ OLIGOMER LOAD, ENHANCES COGNITION, DECELERATES NEURODEGENERATION, REVERSES DISEASE PHENOTYPE IN OLD-AGED TG AD MICE, AND IS SAFE IN HUMANS

      Author(s): , , ,
      Publication date Created:
      Publication date (Print):
      Journal: Alzheimer's & Dementia
      Publisher: Elsevier BV

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Title: Alzheimer's & Dementia
          Abbreviated Title: Alzheimer's & Dementia
          Publisher: Elsevier BV
          ISSN (Print): 15525260
          Publication date Created: July 2019
          Publication date (Print): July 2019
          Volume: 15
          Issue: 7
          Pages: P1233-P1234
          Article
          DOI: 10.1016/j.jalz.2019.06.4751
          SO-VID: 40d53d23-c0a1-4da4-8b25-84b6668100c9
          Copyright © © 2019
          License:

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Data availability:

          Comments

          Comment on this article